| Affiliation: | 1. Lilly Research Laboratories, Indianapolis, IN, USA;2. AstraZeneca, Drug Safety & Metabolism, Mölndal, Sweden;3. AbbVie, Global Preclinical Safety, North Chicago, IL, USA;4. F Hoffmann La Roche, Pharma Research and Early Development, Roche Innovation Center Basel, CH, Switzerland;5. Novartis Pharma AG, Translational Medicine at the Novartis Institutes of Biomedical Research, Basel, Switzerland;1. Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou 350002, China;2. School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China;3. Research Institute of Functional Materials, College of Chemistry and Chemical Engineering, Fuzhou University, Fuzhou 350002, China;1. Institute of Physical Chemistry (as from 1 January 2014: Department of Chemistry), Business Chemistry Group, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland;2. LifeScan, Division of Cilag GmbH International, Johnson & Johnson, Gubelstrasse 34, 6300 Zug, Switzerland;3. Janssen Pharmaceuticals, Pharmaceutical Development & Manufacturing Sciences, Johnson & Johnson, Hochstrasse 201, 8205 Schaffhausen, Switzerland;1. Optibrium Ltd, 7221 Cambridge Research Park, Beach Drive, Cambridge CB25 9TL, UK;2. Lhasa Limited, 22-23 Blenheim Terrace, Woodhouse Lane, Leeds LS2 9HD, UK |
